Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine

Agilent Technologies Inc. (NYSE: A) today announced the launch of its Biopharma CDx Services Lab (BCSL) in Carpinteria, California, after receiving its clinical laboratory license from the State of California and its Clinical Laboratory Improvement Amendments (CLIA) Certificate of Compliance.

These credentials indicate that the lab operates in compliance with CLIA regulations, which are federal standards that apply to all U.S. facilities that test human samples for health assessment, diagnosis, prevention, or treatment of disease. The CLIA Certificate of Conformity ensures high standards of accuracy and reliability in laboratory testing, confirms regulatory compliance, increases market credibility, and improves operational efficiency.